AirSculpt Sets 2026 Guidance After Sales Rebound, Plans Excision Rollout

Overview

• AirSculpt projected 2026 revenue of $151 million to $157 million, assuming about 3% same‑store growth that builds through the year.
• Same‑store sales swung from a 22% decline early in 2025 to growth in February 2026 after the company expanded marketing and core demand steadied.
• The company will expand skin‑removal, known as excision, to every clinic in 2026 after a pilot of more than 100 procedures in the fourth quarter of 2025.
• Management is targeting people who lost weight using GLP‑1 medicines, citing a long‑term market of more than $100 million for skin tightening and contour repair.
• Leaders aim to push net debt below 2.5 times earnings and plan to refinance the term loan using options such as an at‑the‑market share program and equity sales.